CHICAGO – Oncologists seeking high-precision but not very expensive methods for diagnosing lung cancer in patients may not need further examination by the local community for breeding dogs. This is because a new study finds that Beagle is capable of successfully detecting disease by aroma, a major breakthrough in the identification of specific biomarkers of the disease.
Researchers from the American Osteopathic Association say that remarkable dog precision can lead to a safe accessible and effective alternative to cancer screening in the future.
Beagles were chosen because of their enriched smell, even when compared to other breeds of dogs. They are able to distinguish between blood serum samples taken from patients suffering from malignant lung cancer and those who are healthy with 97% accuracy.
"We use the dogs to sort the aroma layers until we identify the story. fabulous biomarkers, "says lead author Thomas Quinn, professor at Osteopathic Medicine College, Lake Erie. "There is still a lot to do, but we are making good progress."
Click here to subscribe to our weekly newsletter and get the latest research from the preview studio. Researchers also work on another segment of the study, which will include a beagle that will smell lung, breast and colorectal cancer from patient samples. They say this study may be the first step in developing a screening test that is comparative with a pregnancy test that can detect lung cancer early enough to be treated.
have a better natural ability to explore cancer than our state-of-the-art technology, "says Quinn. "Once we know what they know and how, we can catch up."
Lung cancer is the leading cause of death for men and women globally. More than 200,000 people in the United States are diagnosed with lung cancer each year.
The study was published in the Journal of the American Osteopathic Association